Package 0006-3066-03

{"route": ["ORAL"], "spl_id": "428f7828-6d1c-438b-a17d-b4af0700c740", "openfda": {"nui": ["N0000010262", "N0000175786", "N0000182141", "N0000185507", "N0000185506"], "unii": ["1NF15YR6UY"], "rxcui": ["403810", "403811", "404465", "404466", "644088", "644278", "754508", "754509", "1729308", "1729311"], "spl_set_id": ["696f9e80-9cae-403b-de9e-078343ce4713"], "pharm_class_epc": ["Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Neurokinin 1 Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]"], "manufacturer_name": ["Merck Sharp & Dohme LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 POUCH in 1 CARTON (0006-3066-03)  / 1 POWDER, FOR SUSPENSION in 1 POUCH (0006-3066-01)", "package_ndc": "0006-3066-03", "marketing_start_date": "20151217"}], "brand_name": "EMEND", "product_id": "0006-3066_428f7828-6d1c-438b-a17d-b4af0700c740", "dosage_form": "POWDER, FOR SUSPENSION", "pharm_class": ["Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Neurokinin 1 Antagonists [MoA]", "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "product_ndc": "0006-3066", "generic_name": "aprepitant", "labeler_name": "Merck Sharp & Dohme LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "EMEND", "active_ingredients": [{"name": "APREPITANT", "strength": "125 mg/1"}], "application_number": "NDA207865", "marketing_category": "NDA", "marketing_start_date": "20151217", "listing_expiration_date": "20261231"}